Fund shareholders of Dyne Therapeutics Inc
ISIN US26818M1080 · United States
- Fund shareholders
- 226
- Of which ETFs
- 50 176 other funds
- Value held
- ≈ 1.1B $ 1.1B $ · 141.5K €
- Share of capital
- 33.5 % of 186.7M shares on Jul 24, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | 7,012,202 | 127.1M $ | 1.58 % | 3.75 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 4,645,637 | 84.2M $ | 0.00 % | 2.49 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 4,625,081 | 83.9M $ | 0.91 % | 2.48 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc. | 3,809,721 | 69.1M $ | 1.59 % | 2.04 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 3,437,524 | 62.3M $ | 0.84 % | 1.84 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Capital Appreciation Fund T. ROWE PRICE CAPITAL APPRECIATION FUND, INC. | 3,279,669 | 59.5M $ | 0.09 % | 1.76 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 ETF iShares Trust | 3,253,081 | 59M $ | 0.08 % | 1.74 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND | 2,528,224 | 45.8M $ | 0.88 % | 1.35 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 1,754,205 | 27.4M $ | 0.03 % | 0.94 % | as of Feb 28, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 1,706,834 | 30.9M $ | 0.02 % | 0.91 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,603,230 | 29.1M $ | 0.04 % | 0.86 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 1,368,144 | 21.4M $ | 0.40 % | 0.73 % | as of Feb 28, 2026 ↗ |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 1,317,799 | 23.1M $ | 0.07 % | 0.71 % | as of Apr 30, 2026 ↗ |
| VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS | 1,086,789 | 19.7M $ | 0.03 % | 0.58 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Growth Fund JPMorgan Trust II | 969,186 | 17.6M $ | 0.81 % | 0.52 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 917,470 | 16.6M $ | 0.20 % | 0.49 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 872,825 | 15.8M $ | 0.12 % | 0.47 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 Value ETF iShares Trust | 777,573 | 14.1M $ | 0.11 % | 0.42 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 753,442 | 11.8M $ | 0.03 % | 0.40 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 700,174 | 10.9M $ | 0.05 % | 0.37 % | as of Feb 28, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Fund JNL Series Trust | 691,258 | 12.5M $ | 0.09 % | 0.37 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 613,184 | 9.6M $ | 0.06 % | 0.33 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 582,369 | 10.6M $ | 0.13 % | 0.31 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 519,232 | 9.1M $ | 0.88 % | 0.28 % | as of Apr 30, 2026 ↗ |
| Franklin Small Cap Growth Fund Franklin Strategic Series | 505,324 | 8.9M $ | 0.36 % | 0.27 % | as of Apr 30, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 504,374 | 7.9M $ | 0.03 % | 0.27 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 482,000 | 8.5M $ | 0.44 % | 0.26 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 469,500 | 7.3M $ | 0.03 % | 0.25 % | as of Feb 28, 2026 ↗ |
| Wasatch Ultra Growth Fund WASATCH FUNDS TRUST | 433,765 | 7.9M $ | 1.96 % | 0.23 % | as of Mar 31, 2026 ↗ |
| Artisan International Small-Mid Fund Artisan Partners Funds Inc. | 398,535 | 7.2M $ | 0.27 % | 0.21 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 390,218 | 6.8M $ | 0.05 % | 0.21 % | as of Apr 30, 2026 ↗ |
| iShares Russell 2000 Growth ETF iShares Trust | 348,206 | 6.3M $ | 0.05 % | 0.19 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Capital Appreciation Equity ETF T. Rowe Price Exchange-Traded Funds, Inc. | 347,796 | 6.3M $ | 0.10 % | 0.19 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 337,675 | 5.3M $ | 0.03 % | 0.18 % | as of Feb 28, 2026 ↗ |
| VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO Voya Investors Trust | 326,259 | 5.9M $ | 0.09 % | 0.17 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Blend Fund JPMorgan Trust I | 312,889 | 5.7M $ | 0.40 % | 0.17 % | as of Mar 31, 2026 ↗ |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 292,654 | 5.1M $ | 0.07 % | 0.16 % | as of Apr 30, 2026 ↗ |
| Nuveen Quant Small Cap Equity Fund TIAA-CREF Funds | 283,050 | 5M $ | 0.13 % | 0.15 % | as of Apr 30, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 278,934 | 4.4M $ | 0.07 % | 0.15 % | as of Feb 27, 2026 ↗ |
| ClearBridge Small Cap Growth Fund Legg Mason Partners Investment Trust | 276,016 | 4.8M $ | 0.24 % | 0.15 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 267,000 | 4.2M $ | 0.00 % | 0.14 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXPLORER FUND VANGUARD EXPLORER FUND | 261,062 | 4.6M $ | 0.02 % | 0.14 % | as of Apr 30, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 234,981 | 4.1M $ | 0.06 % | 0.13 % | as of Apr 30, 2026 ↗ |
| Penn Series Flexibly Managed Fund Penn Series Funds Inc | 234,018 | 4.2M $ | 0.09 % | 0.13 % | as of Mar 31, 2026 ↗ |
| Small Cap Value Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 219,314 | 4M $ | 0.68 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 214,504 | 3.4M $ | 0.00 % | 0.11 % | as of Feb 28, 2026 ↗ |
| Master Small Cap Index Series Quantitative Master Series LLC | 206,225 | 3.7M $ | 0.08 % | 0.11 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Spectrum Moderate Growth Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 200,996 | 3.1M $ | 0.07 % | 0.11 % | as of Feb 28, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 196,941 | 3.5M $ | 0.67 % | 0.11 % | as of Apr 30, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 195,793 | 3.4M $ | 0.02 % | 0.10 % | as of Apr 30, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 193,709 | 3.5M $ | 0.00 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 161,324 | 2.8M $ | 0.00 % | 0.09 % | as of Apr 30, 2026 ↗ |
| Nuveen Small Cap Blend Index Fund TIAA-CREF Funds | 159,573 | 2.8M $ | 0.07 % | 0.09 % | as of Apr 30, 2026 ↗ |
| NORTH SQUARE DYNAMIC SMALL CAP FUND Exchange Place Advisors Trust | 150,980 | 2.4M $ | 0.34 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Multi-Manager Small Cap Equity Strategies Fund COLUMBIA FUNDS SERIES TRUST I | 143,929 | 2.2M $ | 0.18 % | 0.08 % | as of Feb 28, 2026 ↗ |
| EQ/2000 Managed Volatility Portfolio EQ Advisors Trust | 139,179 | 2.5M $ | 0.07 % | 0.07 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 126,396 | 2M $ | 0.04 % | 0.07 % | as of Feb 27, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 123,282 | 2.2M $ | 0.00 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Janus Henderson Small Cap Value Fund JANUS INVESTMENT FUND | 117,004 | 2.1M $ | 0.18 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust | 112,195 | 2M $ | 0.11 % | 0.06 % | as of Mar 31, 2026 ↗ |
| SMALL COMPANY GROWTH PORTFOLIO VANGUARD VARIABLE INSURANCE FUNDS | 105,254 | 1.9M $ | 0.14 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Victory Science & Technology Fund Victory Portfolios III | 102,659 | 1.8M $ | 0.13 % | 0.05 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Small-Mid Cap ETF T. Rowe Price Exchange-Traded Funds, Inc. | 97,095 | 1.8M $ | 0.11 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 96,108 | 1.5M $ | 0.01 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Meridian Growth Fund Meridian Fund Inc | 94,278 | 1.7M $ | 0.35 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 87,330 | 1.5M $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 84,539 | 1.5M $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 83,946 | 1.5M $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 83,800 | 1.5M $ | 0.08 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 83,478 | 1.3M $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 78,548 | 1.4M $ | 0.05 % | 0.04 % | as of Apr 30, 2026 ↗ |
| T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II | 78,426 | 1.4M $ | 0.13 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 77,358 | 1.4M $ | 1.12 % | 0.04 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Spectrum Moderate Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 74,427 | 1.2M $ | 0.06 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 74,141 | 1.3M $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 69,485 | 1.3M $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| EQ/Small Company Index Portfolio EQ Advisors Trust | 67,470 | 1.2M $ | 0.08 % | 0.04 % | as of Mar 31, 2026 ↗ |
| NYLI Fiera SMID Growth Fund NEW YORK LIFE INVESTMENTS FUNDS TRUST | 67,004 | 1.2M $ | 0.51 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Fidelity Enhanced Small Cap ETF Fidelity Covington Trust | 66,209 | 1.2M $ | 0.03 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 VALUE INDEX FUND VANGUARD SCOTTSDALE FUNDS | 62,028 | 968.9K $ | 0.09 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Small Cap Index Fund Northern Funds | 61,937 | 1.1M $ | 0.08 % | 0.03 % | as of Mar 31, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 60,951 | 1.1M $ | 0.59 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Victory Small Cap Stock Fund Victory Portfolios III | 58,464 | 1M $ | 0.11 % | 0.03 % | as of Apr 30, 2026 ↗ |
| iShares ESG Aware MSCI USA Small-Cap ETF iShares Trust | 57,944 | 905.1K $ | 0.04 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Global X Russell 2000 ETF GLOBAL X FUNDS | 57,752 | 1M $ | 0.07 % | 0.03 % | as of Apr 30, 2026 ↗ |
| ClearBridge Variable Small Cap Growth Portfolio Legg Mason Partners Variable Equity Trust | 54,200 | 982.6K $ | 0.25 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 53,716 | 942.7K $ | 0.03 % | 0.03 % | as of Apr 30, 2026 ↗ |
| LVIP Franklin Templeton Multi-Factor SMID Cap Equity Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 51,899 | 940.9K $ | 0.10 % | 0.03 % | as of Mar 31, 2026 ↗ |
| JPMorgan BetaBuilders U.S. Small Cap Equity ETF J.P. Morgan Exchange-Traded Fund Trust | 51,630 | 906.1K $ | 0.12 % | 0.03 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 51,543 | 934.5K $ | 0.07 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Capital Appreciation Value Fund John Hancock Funds II | 51,518 | 804.7K $ | 0.07 % | 0.03 % | as of Feb 28, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Equity Fund JNL Series Trust | 50,900 | 922.8K $ | 0.10 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Small Company Value Trust John Hancock Variable Insurance Trust | 50,680 | 918.8K $ | 0.71 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Small Cap Index Fund VALIC Co I | 50,384 | 787K $ | 0.06 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 50,359 | 883.8K $ | 0.04 % | 0.03 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Spectrum Conservative Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 48,658 | 760K $ | 0.04 % | 0.03 % | as of Feb 28, 2026 ↗ |
| VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS | 48,233 | 874.5K $ | 0.04 % | 0.03 % | as of Mar 31, 2026 ↗ |
| VANGUARD U.S. MOMENTUM FACTOR ETF VANGUARD WELLINGTON FUND | 47,034 | 734.7K $ | 0.05 % | 0.03 % | as of Feb 28, 2026 ↗ |
| STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO STATE STREET INSTITUTIONAL INVESTMENT TRUST | 46,500 | 843K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| AZL T Rowe Price Capital Appreciation Fund Allianz Variable Insurance Products Trust | 44,344 | 804K $ | 0.09 % | 0.02 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Neuroscience and Healthcare ETF iShares Trust | 2.36 % | as of Apr 30, 2026 ↗ |
| Wasatch Ultra Growth Fund WASATCH FUNDS TRUST | 1.96 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 1.88 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc. | 1.59 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | 1.58 % | as of Mar 31, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 1.12 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 0.91 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND | 0.88 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.88 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.84 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 225 | +2 | 62,610,298 | +22.8 % |
| 2026Q1 | 223 | +16 | 51,004,170 | +38.9 % |
| 2025Q4 | 207 | +13 | 36,727,646 | +21.3 % |
| 2025Q3 | 194 | -7 | 30,273,414 | +2.7 % |
| 2025Q2 | 201 | -11 | 29,477,927 | +2.7 % |
| 2025Q1 | 212 | -21 | 28,711,355 | -12.5 % |
| 2024Q4 | 233 | +23 | 32,817,223 | +27.1 % |
| 2024Q3 | 210 | +32 | 25,811,309 | +34.6 % |
| 2024Q2 | 178 | +20 | 19,177,088 | +48.7 % |
| 2024Q1 | 158 | -7 | 12,892,346 | +13.5 % |
| 2023Q4 | 165 | 11,359,327 |
Institutional managers
220 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 30,785,801 | 558.1K $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 13,647,376 | 247.4M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 11,699,870 | 212.1M $ | as of Mar 31, 2026 |
| Atlas Venture Life Science Advisors, LLC | 9,130,465 | 165.5M $ | as of Mar 31, 2026 |
| FMR LLC | 8,908,980 | 161.5M $ | as of Mar 31, 2026 |
| Orbis Allan Gray Ltd | 6,762,231 | 122.6M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 6,653,746 | 120.6M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 4,668,839 | 84.6M $ | as of Mar 31, 2026 |
| FCPM III SERVICES B.V. | 4,644,386 | 84.2M $ | as of Mar 31, 2026 |
| TCG Crossover Management, LLC | 4,615,144 | 83.7M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 4,000,000 | 72.5M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,504,114 | 63.5M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 3,253,473 | 55.6M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 3,175,110 | 57.6M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 3,153,082 | 57.2M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 2,917,884 | 52.9M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,328,373 | 42.2K $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 2,229,125 | 40.4M $ | as of Mar 31, 2026 |
| Venrock Adviser, LLC | 2,173,913 | 39.4M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 2,009,082 | 36.4M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 2,000,000 | 36.3M $ | as of Mar 31, 2026 |
| SAMLYN CAPITAL, LLC | 1,922,543 | 34.9M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,723,116 | 31.2M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 1,681,998 | 30.5M $ | as of Mar 31, 2026 |
| Palo Alto Investors LP | 1,652,972 | 30M $ | as of Mar 31, 2026 |
Declared shareholders of Dyne Therapeutics Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 18.70 % | 30,785,801 | as of Mar 31, 2026 · SCHEDULE 13G |
| JANUS HENDERSON GROUP PLC | 8.30 % | 13,647,376 | as of Mar 31, 2026 · SCHEDULE 13G |
| FMR LLC and 1 other | 5.40 % | 8,908,980 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Dyne Therapeutics Inc". https://titelia.com/en/stocks/dyne-therapeutics-inc-US26818M1080